CASP9
CASP9 (caspase 9, also known as MCH6, ICE-LAP6, APAF-3 and PPP1R56) is a cysteine-aspartic acid protease of the caspase family. It is activated by the apoptosome and is thought to act early in the caspase cascade that drives apoptosis. Browse Assay Genie's current range of CASP9 research reagents below, or read on for the biology behind the target.
CASP9 encodes caspase-9, a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution phase of apoptosis. Caspases exist as inactive proenzymes, which are processed proteolytically at conserved aspartic acid residues to give a large and a small subunit. These subunits dimerise to form the active enzyme.
Caspase-9 can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and apoptotic peptidase activating factor 1. This step is thought to be one of the earliest in the caspase activation cascade. The protein is thought to play a central role in apoptosis and to act as a tumour suppressor. The CASP9 gene undergoes alternative splicing, giving multiple transcript variants. UniProt notes that one form lacks activity and acts as a dominant-negative inhibitor of caspase-9.
Caspase-9 belongs to the peptidase C14A family. In HGNC it is classified within the caspases, the caspase recruitment domain containing proteins and the apoptosome gene groups, and it also carries the protein phosphatase 1 regulatory subunit symbol PPP1R56. Earlier names include caspase 9, apoptosis-related cysteine protease, and the aliases MCH6, ICE-LAP6 and APAF-3 appear in the literature. Researchers studying CASP9 often work alongside other caspases to map apoptotic signalling.
Caspase-9 is thought to play a central role in apoptosis and sits at an early step of the caspase activation cascade.
Caspase-9 is activated by the apoptosome, a complex of cytochrome c and apoptotic peptidase activating factor 1.
The protein is thought to act as a tumour suppressor, making it relevant to studies of cell death regulation in cancer.
Proenzyme cleavage at conserved aspartic residues and subunit dimerisation make caspase-9 a model for protease activation.
CASP9 encodes caspase-9, a cysteine-aspartic acid protease that is activated by the apoptosome and is thought to act in one of the earliest steps of the caspase activation cascade. It is considered to play a central role in apoptosis and to be a tumour suppressor.
CASP9 is also known as MCH6, ICE-LAP6, APAF-3 and PPP1R56, and its protein is called caspase-9. Alternative splicing produces multiple transcript variants. UniProt describes one form that lacks activity and acts as a dominant-negative inhibitor of caspase-9.
A mouse ortholog, Casp9, is recorded for this gene. Caspase-9 belongs to the peptidase C14A family, within the wider caspase family. Check the datasheet of any product for its validated reactivity.
Other caspase family members and apoptosis pathway targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P55211; product specifications from Assay Genie datasheets.